Ennis, Inc. (NYSE:EBF – Get Free Report) announced a quarterly dividend on Sunday, June 23rd, Wall Street Journal reports. Investors of record on Friday, October 11th will be paid a dividend of 0.25 per share by the industrial products company on Friday, November 8th. This represents a $1.00 annualized dividend and a dividend yield of 4.17%. The ex-dividend date is Friday, October 11th.
Ennis has raised its dividend by an average of 3.6% annually over the last three years.
Ennis Trading Down 2.2 %
EBF stock opened at $24.00 on Wednesday. The firm has a market cap of $623.62 million, a PE ratio of 15.00 and a beta of 0.40. The stock has a 50-day moving average price of $23.41 and a 200-day moving average price of $21.89. Ennis has a 1-year low of $18.88 and a 1-year high of $25.75.
Analysts Set New Price Targets
View Our Latest Research Report on EBF
Ennis Company Profile
Ennis, Inc manufactures and sells business forms and other business products in the United States. The company offers snap sets, continuous forms, laser cut sheets, tags, labels, envelopes, integrated products, jumbo rolls, and pressure sensitive products under the Ennis, Royal Business Forms, Block Graphics, 360º Custom Labels, ColorWorx, Enfusion, Uncompromised Check Solutions, VersaSeal, Ad Concepts, FormSource Limited, Star Award Ribbon Company, Witt Printing, B&D Litho, Genforms, PrintGraphics, Calibrated Forms, PrintXcel, Printegra, Forms Manufacturers, Mutual Graphics, TRI-C Business Forms, Major Business Systems, Independent Printing, Hoosier Data Forms, Hayes Graphics, Wright Business Graphics, Wright 360, Integrated Print & Graphics, the Flesh Company, Impressions Direct, and AmeriPrint brands.
Further Reading
- Five stocks we like better than Ennis
- How to Capture the Benefits of Dividend Increases
- This Major Sell-Off in Chinese Stocks Could Be Your Buy Signal
- What is a Secondary Public Offering? What Investors Need to Know
- Two High-Yield ETF Cash Machines for Your Retirement Portfolio
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Don’t Sleep on Skye Bioscience—This Weight Loss Drug Could Soar
Receive News & Ratings for Ennis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ennis and related companies with MarketBeat.com's FREE daily email newsletter.